EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole

Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial

Thomas J. Walsh, Issam Raad, Thomas F. Patterson et al. · Clinical Infectious Diseases · 2006 · 750 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Frequency and Evolution of Azole Resistance in<i>Aspergillus fumigatus</i>Associated with Treatment Failure1

Susan J. Howard, Daša Cerar, Michael J. Anderson et al. · Emerging infectious diseases · 2009 · 749 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A New <i>Aspergillus fumigatus</i> Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of <i>cyp51A</i> Alterations

Emilia Mellado, Guillermo García‐Effrón, Laura Alcázar‐Fuoli et al. · Antimicrobial Agents and Chemotherapy · 2007 · 498 citations · Full text

Life Sciences, Genetics, Microbiology +16

NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis

David W. Denning, Jeanette Y. Lee, J.S. Hostetler et al. · The American Journal of Medicine · 1994 · 451 citations · Full text

Medicine, Infectious Diseases, Microbiology +17

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

Ahmed S. Bueid, S. J. Howard, Caroline B. Moore et al. · Journal of Antimicrobial Chemotherapy · 2010 · 337 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17